GHRYVELIN 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
IB/0022 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
08/01/2024 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
T/0021 
Transfer of Marketing Authorisation 
25/08/2023 
11/09/2023 
SmPC, 
Labelling and 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
01/09/2022 
n/a 
PRAC Recommendation - maintenance 
/202201 
macimorelin 
PL 
IB/0018 
B.II.d.1.z - Change in the specification parameters 
09/08/2022 
n/a 
and/or limits of the finished product - Other variation 
IA/0019 
A.4 - Administrative change - Change in the name 
25/07/2022 
n/a 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
10/02/2022 
n/a 
PRAC Recommendation - maintenance 
/202107 
macimorelin 
IAIN/0016 
A.2.a - Administrative change - Change in the 
16/11/2021 
09/11/2022 
SmPC, 
(invented) name of the medicinal product for CAPs 
Labelling and 
PL 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
02/09/2021 
n/a 
PRAC Recommendation - maintenance 
/202101 
macimorelin 
T/0012 
Transfer of Marketing Authorisation 
31/03/2021 
21/04/2021 
SmPC, 
Labelling and 
PL 
IAIN/0013 
A.2.a - Administrative change - Change in the 
30/03/2021 
16/04/2021 
SmPC, 
(invented) name of the medicinal product for CAPs 
Labelling and 
PL 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
11/02/2021 
n/a 
PRAC Recommendation - maintenance 
Page 2/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/202007 
macimorelin 
IA/0011 
B.I.b.2.c - Change in test procedure for AS or 
05/02/2021 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
IA/0009/G 
This was an application for a group of variations. 
08/01/2021 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
IA/0010 
B.II.d.2.a - Change in test procedure for the finished 
06/01/2021 
n/a 
product - Minor changes to an approved test 
Page 3/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
procedure 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
03/09/2020 
n/a 
PRAC Recommendation - maintenance 
/202001 
macimorelin 
IB/0007/G 
This was an application for a group of variations. 
21/07/2020 
n/a 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
PSUSA/10746
Periodic Safety Update EU Single assessment - 
16/01/2020 
n/a 
PRAC Recommendation - maintenance 
/201907 
macimorelin 
IA/0005/G 
This was an application for a group of variations. 
20/12/2019 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
Page 4/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.a.4.a - Change to in-process tests or limits 
applied during the manufacture of the AS - 
Tightening of in-process limits 
B.I.a.4.a - Change to in-process tests or limits 
applied during the manufacture of the AS - 
Tightening of in-process limits 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IA/0003 
B.I.c.2.c - Change in the specification parameters 
14/05/2019 
n/a 
and/or limits of the immediate packaging of the AS - 
Deletion of a non-significant specification parameter 
(e.g. deletion of an obsolete parameter) 
II/0001 
B.II.d.1.e - Change in the specification parameters 
02/05/2019 
n/a 
and/or limits of the finished product - Change 
outside the approved specifications limits range 
IA/0002/G 
This was an application for a group of variations. 
29/04/2019 
n/a 
Page 5/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
Page 6/6 
 
 
 
 
 
 
 
 
